Chávez-Cartaya RE et al. |
Rat liver blood flow after ischemia and reperfusion. The effects of the platelet-activating factor antagonist WEB-2170 and of removing circulating leukocytes. |
1994 |
Transplantation |
pmid:8197604
|
Pi F et al. |
Effect of a platelet-activating factor antagonist and desferrioxamine administration on eicosanoid production in rat pancreas transplantation. |
1994 |
Transplantation |
pmid:8291097
|
Lanese DM et al. |
Sequential agonist activation and site-specific mediation of acute cyclosporine constriction in rat renal arterioles. |
1994 |
Transplantation |
pmid:7809931
|
dos Santos OF et al. |
Effect of platelet-activating factor antagonist on cyclosporine nephrotoxicity. Glomerular hemodynamics evaluation. |
1989 |
Transplantation |
pmid:2705209
|
Biancone L et al. |
Platelet-activating factor synthesis and response on pancreatic islet endothelial cells: relevance for islet transplantation. |
2006 |
Transplantation |
pmid:16495796
|
Saumweber DM et al. |
Hyperacute rejection in an ex vivo model of renal xenografting. Role of the mediator response and its pharmacologic manipulation by the specific platelet-activating factor antagonist WEB 2086BS. |
1994 |
Transplantation |
pmid:8108870
|
Yin M et al. |
The PAF antagonist TCV-309 reduces graft PMN infiltration and enhances early function of 24-hour-preserved rat kidneys with long warm ischemia. |
1996 |
Transplantation |
pmid:8633367
|
Nishiyama R et al. |
Platelet-activating factor in hepatic ischemia/reperfusion injury. The effects of a PAF antagonist combined with a prostaglandin I2 analogue. |
1993 |
Transplantation |
pmid:8516812
|
Kawahara K et al. |
The effect of the platelet-activating factor inhibitor TCV-309 on reperfusion injury in a canine model of ischemic lung. |
1993 |
Transplantation |
pmid:8516834
|
Takada Y et al. |
Effects of platelet-activating factor antagonist on preservation/reperfusion injury of the graft in porcine orthotopic liver transplantation. |
1995 |
Transplantation |
pmid:7839408
|
Watson CJ et al. |
The platelet-activating factor antagonist WEB 2170. Its beneficial effect on dog renal allograft survival. |
1993 |
Transplantation |
pmid:8212192
|
Marathe GK et al. |
Oxidized LDL contains inflammatory PAF-like phospholipids. |
2001 Apr-May |
Trends Cardiovasc. Med. |
pmid:11686003
|
Zimmerman GA and McIntyre TM |
PAF, ceramide and pulmonary edema: alveolar flooding and a flood of questions. |
2004 |
Trends Mol Med |
pmid:15177186
|
Braquet P et al. |
Is there a case for PAF antagonists in the treatment of ischemic states? |
1989 |
Trends Pharmacol. Sci. |
pmid:2688213
|
Izzo AA et al. |
Recent findings on the mode of action of laxatives: the role of platelet activating factor and nitric oxide. |
1998 |
Trends Pharmacol. Sci. |
pmid:9803830
|
Page C and Abbott A |
PAF: new antagonists, new roles in disease and a major role in reproductive biology. |
1989 |
Trends Pharmacol. Sci. |
pmid:2672467
|
GarcÃa-Sáinz JA |
Intercellular communication within the liver has clinical implications. |
1989 |
Trends Pharmacol. Sci. |
pmid:2595791
|
O'Neill C |
A physiological role for PAF in the stimulation of mammalian embryonic development. |
1991 |
Trends Pharmacol. Sci. |
pmid:2053190
|
GamaleÄ IA et al. |
[Post-receptor formation of active forms of oxygen in nonphagocytic cells]. |
1999 |
Tsitologiia |
pmid:10496012
|
Harputluoglu MM et al. |
The effects of Gingko biloba extract on acetic acid-induced colitis in rats. |
2006 |
Turk J Gastroenterol |
pmid:16941250
|